Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX4 | Q96LA9 | 4/20 | 0.57 |
| ▸ | NPC1 | O15118 | 6/20 | 0.57 |
| ▸ | RAB9A | P51151 | 6/20 | 0.57 |
| ▸ | MEN1 | O00255 | 5/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.57 |
| ▸ | POLB | P06746 | 3/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.54 |
| ▸ | PPARG | P37231 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | NR1H4 | Q96RI1 | 3/20 | 0.48 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.47 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.47 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.47 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.47 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.47 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ARHGEF12 | Q9NZN5 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31338661 | 1.00 | MRGPRX4 (0.57) | MRGPRX4NPC1RAB9AMEN1KMT2A | |
| SCHEMBL20772352 | 0.91 | NPC1 (0.58) | NPC1RAB9AMEN1KMT2APOLB | |
| SCHEMBL22028726 | 0.91 | PPARG (0.64) | MRGPRX4NPC1RAB9AMEN1KMT2A | |
| SCHEMBL31338663 | 0.91 | NPC1 (0.58) | NPC1RAB9AMEN1KMT2APOLB | |
| SCHEMBL31338662 | 0.91 | PPARG (0.64) | MRGPRX4NPC1RAB9AMEN1KMT2A | |
| SCHEMBL13044232 | 0.82 | MEN1 (0.76) | NPC1RAB9AMEN1KMT2APOLB | |
| SCHEMBL20772245 | 0.81 | ALDH1A1 (0.53) | MRGPRX4NPC1RAB9AKMT2APOLB | |
| SCHEMBL30057589 | 0.81 | ALDH1A1 (0.53) | MRGPRX4NPC1RAB9AKMT2APOLB | |
| SCHEMBL9369666 | 0.81 | MRGPRX4 (0.69) | MRGPRX4NPC1RAB9ATDP1SMN1; SMN2 | |
| SCHEMBL25058825 | 0.81 | KMT2A (0.63) | NPC1RAB9AMEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4219458-A2 | NOVEL BARBITURIC ACID DERIVATIVES, THEIR PREPARATION AND USE THEREOF AS LEUKOCYTE TRANSMIGRATION INHIBITORS AND FOR TREATING INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES AND CANCER | Bar Ilan University (IL) | 2023-08-02 | — | — | EP | disclosed |
| EP-4219458-A2 | NOVEL BARBITURIC ACID DERIVATIVES, THEIR PREPARATION AND USE THEREOF AS LEUKOCYTE TRANSMIGRATION INHIBITORS AND FOR TREATING INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES AND CANCER | Bar Ilan University (IL) | 2023-08-02 | — | — | EP | disclosed |
| US-20230150949-A1 | NOVEL BARBITURIC ACID DERIVATIVES, THEIR PREPARATION AND USE THEREOF AS LEUKOCYTE TRANSMIGRATION INHIBITORS AND FOR TREATING INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES AND CANCER | UNIV BAR ILAN (IL) | 2023-05-18 | — | — | US | disclosed |
| US-20230150949-A1 | NOVEL BARBITURIC ACID DERIVATIVES, THEIR PREPARATION AND USE THEREOF AS LEUKOCYTE TRANSMIGRATION INHIBITORS AND FOR TREATING INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES AND CANCER | UNIV BAR ILAN (IL) | 2023-05-18 | — | — | US | disclosed |
| US-20230150949-A1 | NOVEL BARBITURIC ACID DERIVATIVES, THEIR PREPARATION AND USE THEREOF AS LEUKOCYTE TRANSMIGRATION INHIBITORS AND FOR TREATING INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES AND CANCER | UNIV BAR ILAN (IL) | 2023-05-18 | — | — | US | disclosed |
| EP-3676256-B1 | NOVEL BARBITURIC ACID DERIVATIVES, THEIR PREPARATION AND USE THEREOF AS LEUKOCYTE TRANSMIGRATION INHIBITORS AND FOR TREATING INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES AND CANCER | UNIV BAR ILAN (IL) | 2023-02-22 | — | — | EP | disclosed |
| EP-3676256-B1 | NOVEL BARBITURIC ACID DERIVATIVES, THEIR PREPARATION AND USE THEREOF AS LEUKOCYTE TRANSMIGRATION INHIBITORS AND FOR TREATING INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES AND CANCER | UNIV BAR ILAN (IL) | 2023-02-22 | — | — | EP | disclosed |
| EP-3676256-A1 | NOVEL BARBITURIC ACID DERIVATIVES, THEIR PREPARATION AND USE THEREOF AS LEUKOCYTE TRANSMIGRATION INHIBITORS AND FOR TREATING INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES AND CANCER | Bar Ilan University (IL) | 2020-07-08 | — | — | EP | disclosed |
| US-20200181094-A1 | NOVEL BARBITURIC ACID DERIVATIVES, THEIR PREPARATION AND USE THEREOF AS LEUKOCYTE TRANSMIGRATION INHIBITORS AND FOR TREATING INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES AND CANCER | GENEVA UNIVERSITY HOSPITALS (CH) | 2020-06-11 | — | — | US | disclosed |
| US-20200181094-A1 | NOVEL BARBITURIC ACID DERIVATIVES, THEIR PREPARATION AND USE THEREOF AS LEUKOCYTE TRANSMIGRATION INHIBITORS AND FOR TREATING INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES AND CANCER | GENEVA UNIVERSITY HOSPITALS (CH) | 2020-06-11 | — | — | US | disclosed |
| WO-2019043706-A1 | NOVEL BARBITURIC ACID DERIVATIVES, THEIR PREPARATION AND USE THEREOF AS LEUKOCYTE TRANSMIGRATION INHIBITORS AND FOR TREATING INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES AND CANCER | BAR-ILAN UNIVERSITY (IL) | 2019-03-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150949-A1 | NOVEL BARBITURIC ACID DERIVATIVES, THEIR PREPARATION AND USE THEREOF AS LEUKOCYTE TRANSMIGRATION INHIBITORS AND FOR TREATING INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES AND CANCER | ICAM1, NFKBIA, SLC6A1 | MRGPRX4 811/4885NPC1 1455/4885RAB9A 1091/4885 |
| US-20200181094-A1 | NOVEL BARBITURIC ACID DERIVATIVES, THEIR PREPARATION AND USE THEREOF AS LEUKOCYTE TRANSMIGRATION INHIBITORS AND FOR TREATING INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES AND CANCER | ICAM1, NFKBIA, SLC6A1 | MRGPRX4 811/4885NPC1 1455/4885RAB9A 1091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.